The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20062006
Dougan et al.

• Figure S1 MTPv1-mediated phospholipid transfer is susceptible to MTP inhibitors.

• Figure S2 MTP inhibitor BMS200150 does not affect CD1d surface expression on FTOC cells.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS